Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 1

Status

Completed 19Recruiting 9Unknown 7Terminated 4Active not recruiting 4Not yet recruiting 2Withdrawn 1Enrolling by invitation 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 4

Conditions

Breast Neoplasms 4Triple Negative Breast Neoplasms 1

Interventions

Cyclophosphamide 241Radiotherapy 217Gemcitabine 187Cisplatin 185Carboplatin 182Docetaxel 166Bevacizumab 166Paclitaxel 144Capecitabine 142Rituximab 141pembrolizumab 140Nivolumab 126Oxaliplatin 124Dexamethasone 122Fluorouracil 113fludarabine 104Radiosurgery 101Doxorubicin 99fludarabine phosphate 97Irinotecan 96Etoposide 95Lenalidomide 93Cytarabine 92Magnetic Resonance Spectroscopy 90Radiation 89Filgrastim 89Leucovorin 88Bortezomib 86Cetuximab 80Pemetrexed 79

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Terminated × OTHER × Mastectomy × Clear all
NCT00210236 2025-10-20

AXIL95

Institut Bergonié

Phase 3 Terminated
625 enrolled 8 charts
Breast

Breast Neoplasms

NCT01234532 2022-05-03

0927GCC

University of Maryland, Baltimore

Phase 2 Terminated
5 enrolled 7 charts
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT01167192 2016-12-30

Neoadjuvant Platinum-based Chemoradiation Therapy for Locally Advanced Triple Negative Breast Cancer

Washington University School of Medicine

Phase 2 Terminated
10 enrolled 8 charts
Breast

Breast Neoplasms

NCT00603408 2016-08-19

Effect of Chemotherapy and Radiation Prior to Surgery for Triple Negative Breast Cancer

Washington University School of Medicine

Phase 2 Terminated
5 enrolled 7 charts
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡